Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2007 4
2008 6
2009 1
2011 7
2012 4
2013 8
2014 9
2015 5
2016 5
2017 3
2018 2
2019 3
2020 7
2021 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Vaping and lung cancer - A review of current data and recommendations.
Bracken-Clarke D, Kapoor D, Baird AM, Buchanan PJ, Gately K, Cuffe S, Finn SP. Bracken-Clarke D, et al. Among authors: gately k. Lung Cancer. 2021 Mar;153:11-20. doi: 10.1016/j.lungcan.2020.12.030. Epub 2021 Jan 2. Lung Cancer. 2021. PMID: 33429159 Review.
Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer.
O'Sullivan É, Keogh A, Henderson B, Finn SP, Gray SG, Gately K. O'Sullivan É, et al. Among authors: gately k. Cancers (Basel). 2023 Mar 7;15(6):1635. doi: 10.3390/cancers15061635. Cancers (Basel). 2023. PMID: 36980522 Free PMC article. Review.
Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer.
Collins DM, Madden SF, Gaynor N, AlSultan D, Le Gal M, Eustace AJ, Gately KA, Hughes C, Davies AM, Mahgoub T, Ballot J, Toomey S, O'Connor DP, Gallagher WM, Holmes FA, Espina V, Liotta L, Hennessy BT, O'Byrne KJ, Hasmann M, Bossenmaier B, O'Donovan N, Crown J. Collins DM, et al. Among authors: gately ka. Clin Cancer Res. 2021 Feb 1;27(3):807-818. doi: 10.1158/1078-0432.CCR-20-2007. Epub 2020 Oct 29. Clin Cancer Res. 2021. PMID: 33122343 Free PMC article. Clinical Trial.
Protein Tyrosine Phosphatase Non-Receptor 11 (PTPN11/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC).
Richards CE, Elamin YY, Carr A, Gately K, Rafee S, Cremona M, Hanrahan E, Smyth R, Ryan D, Morgan RK, Kennedy S, Hudson L, Fay J, O'Byrne K, Hennessy BT, Toomey S. Richards CE, et al. Among authors: gately k. Int J Mol Sci. 2023 Jun 23;24(13):10545. doi: 10.3390/ijms241310545. Int J Mol Sci. 2023. PMID: 37445722 Free PMC article.
PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer.
Luszczak S, Kumar C, Sathyadevan VK, Simpson BS, Gately KA, Whitaker HC, Heavey S. Luszczak S, et al. Among authors: gately ka. Signal Transduct Target Ther. 2020 Jan 31;5(1):7. doi: 10.1038/s41392-020-0109-y. Signal Transduct Target Ther. 2020. PMID: 32296034 Free PMC article. Review.
Thymidine Phosphorylase in Cancer; Enemy or Friend?
Elamin YY, Rafee S, Osman N, O Byrne KJ, Gately K. Elamin YY, et al. Among authors: gately k. Cancer Microenviron. 2016 Apr;9(1):33-43. doi: 10.1007/s12307-015-0173-y. Epub 2015 Aug 23. Cancer Microenviron. 2016. PMID: 26298314 Free PMC article. Review.
Targeting the fibroblast growth factor receptor family in cancer.
Hallinan N, Finn S, Cuffe S, Rafee S, O'Byrne K, Gately K. Hallinan N, et al. Among authors: gately k. Cancer Treat Rev. 2016 May;46:51-62. doi: 10.1016/j.ctrv.2016.03.015. Epub 2016 Apr 12. Cancer Treat Rev. 2016. PMID: 27109926 Review.
Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC.
Moore G, Lightner C, Elbai S, Brady L, Nicholson S, Ryan R, O'Sullivan KE, O'Byrne KJ, Blanco-Aparicio C, Cuffe S, O'Neill M, Heavey S, Finn SP, Gately K. Moore G, et al. Among authors: gately k. Cancers (Basel). 2021 Apr 29;13(9):2139. doi: 10.3390/cancers13092139. Cancers (Basel). 2021. PMID: 33946744 Free PMC article.
Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC.
Ryan SL, Beard S, Barr MP, Umezawa K, Heavey S, Godwin P, Gray SG, Cormican D, Finn SP, Gately KA, Davies AM, Thompson EW, Richard DJ, O'Byrne KJ, Adams MN, Baird AM. Ryan SL, et al. Among authors: gately ka. Lung Cancer. 2019 Sep;135:217-227. doi: 10.1016/j.lungcan.2019.07.006. Epub 2019 Jul 12. Lung Cancer. 2019. PMID: 31446998
62 results